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ABSTRACT
Objective: To assess whether retail sales of non-
prescription products can be used for syndromic
surveillance and whether it can detect influenza activity
at different spatial scales. A secondary objective was to
assess whether changes in purchasing behaviour were
related to public health advice or levels of media or
public interest.
Setting: The UK.
Participants: National and regional influenza case
estimates and retail sales from a major British
supermarket.
Outcome measures: Weekly, seasonally adjusted
sales of over-the-counter symptom remedies and
non-pharmaceutical products; recommended as part of
the advice offered by public health agencies; were
compared with weekly influenza case estimates.
Comparisons were made at national and regional
spatial resolutions. We also compared sales to national
measures of contemporaneous media output and
public interest (Internet search volume) related to the
pandemic.
Results: At a national scale there was no significant
correlation between retail sales of symptom remedies
and cases for the whole pandemic period in 2009. At
the regional scale, a minority of regions showed
statistically significant positive correlations between
cases and sales of adult ‘cold and flu’ remedies and
cough remedies (3.2%, 5/156, 3.8%, 6/156), but a
greater number of regions showed a significant
positive correlation between cases and symptomatic
remedies for children (35.6%, 55/156). Significant
positive correlations between cases and sales of
thermometers and antiviral hand gels/wash were seen
at both spatial scales (Cor 0.477 (95% CI 0.171 to
0.699); 0.711 (95% CI 0.495 to 0.844)). We found no
significant association between retail sales and media
reporting or Internet search volume.
Conclusions: This study provides evidence that the
British public responded appropriately to health
messaging about hygiene. Non-prescription retail sales
at a national level are not useful for the detection of
cases. However, at finer spatial scales, in particular
age-groups, retail sales may help augment existing
surveillance and merit further study.
INTRODUCTION
Public health surveillance has traditionally
relied on healthcare providers reporting
selected notiﬁable conditions, usually with
biological conﬁrmation.1 Although a key part
of national and international health regula-
tions, this system has well-recognised pro-
blems including delays in reporting and
difﬁculty in identifying unusual activity.2
Expansion of non-traditional surveillance
methods has occurred over the past two
decades, initially because of concerns regard-
ing bioterrorism, and has now been adopted
into routine public health systems in many
countries. These methods (often referred to
as Syndromic Surveillance Systems) offer a
real-time or near-real-time collection of data
from a variety of sources, ideally in an auto-
mated manner which allows early identiﬁca-
tion of the spread and impact of emerging
public health threats and better estimates of
incidence in seasonal outbreaks.3 The 2009
Strengths and limitations of this study
▪ This study is the first to examine associations
between non-prescription retail sales and influ-
enza cases at different spatial resolutions in a
British setting and in particular it’s potential as
part of syndromic surveillance systems.
▪ The adjustment for seasonality in retail sales was
fitted for each spatial resolution in an attempt to
capture regional differences which may exist.
▪ The inclusion of non-pharmaceutical products
allowed for the first objective assessment of the
response to government public health
messaging.
▪ The main weakness of this study is that regional
data were available only for England and for a
portion of the 2009/2010 pandemic period.
▪ Increasing the years of sales data prior to the
pandemic period would have provided a more
robust estimate of sales trend in a typical year.
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inﬂuenza pandemic provided the motivation to adopt
and appraise many of these methods.4 5 In the UK many
of the lessons learned during this time were subse-
quently adopted during the 2012 Olympics and
Paralympics to identify any early infectious disease
threat.6
The surveillance of infectious diseases can be strongly
affected by the care-seeking behaviour of individuals.7 As
many individuals will self-medicate for mild illness, sur-
veillance of non-prescription sales has been suggested as
an adjunct to healthcare-based surveillance to estimate
the magnitude and dynamics of care seeking behaviour.8
Its usefulness for surveillance of seasonal inﬂuenza9–13
and other illnesses14–17 has been examined for over
30 years with varying degrees of success. A major poten-
tial beneﬁt of this type of surveillance system would be
to provide more reliable estimates of incidence when
the propensity to seek care is low or changeable, and to
identify early-stage epidemics through unusual purchas-
ing activity. Additionally, this type of surveillance may
also provide more ﬁnely resolved spatiotemporal infor-
mation on incidence. At present, retail sales are not
used for syndromic surveillance in Great Britain.
The ﬁrst two cases of inﬂuenza A H1N1 2009/pdm in
the UK were conﬁrmed on 27 April 2009.18 There was a
considerable media response before this and through
the summer months. In addition to this a major govern-
ment campaign was launched (‘Catch it, Kill it, Bin it’).
This encouraged the use of clean tissues and regular
hand washing/use of alcohol hand gel. A leaﬂet was dis-
tributed to every household in the UK on 5 May 2009
with this hygiene advice and also included information
on accessing clinical advice.19 As part of the response
within England the National Pandemic Flu Service
(NPFS) was established which provided online and tele-
phone advice to individuals including access to antiviral
medication, this started on 23 July 2009 and operated
until 10 February 2010. This was offered as an alternative
to usual primary care services.20
We describe the temporal and spatial patterns of sales
of over-the-counter ﬂu and cold remedies and non-
pharmaceutical products, recommended as part of the
advice offered by public health agencies, sold by a major
British supermarket. We compare these patterns to
national, regional and subregional estimated cases of
pandemic inﬂuenza during 2009 in Great Britain. We
also compare the pattern of sales to national measures
of media output and public interest (internet search
volume) related to the pandemic during the same time




The weekly estimates of inﬂuenza cases were obtained
via the Health Protection Agency (HPA; now part of
Public Health England) as part of their inﬂuenza
surveillance systems (table 1).21 UK-wide data were calcu-
lated via the FluSurvey project (http://www.ﬂusurvey.
org) which adjusted healthcare-based surveillance system
outputs to account for changes in care-seeking behav-
iour during the pandemic; the study directly estimated
the propensity of individuals to seek care (and therefore
contribute to surveillance estimates) during the pan-
demic through an online survey of a community cohort
and indirectly through NPFS consultation.22 Regional
case data were available through the HPA/
Q-Surveillance network which monitors diagnoses of
inﬂuenza-like-illness (ILI) recorded by general practi-
tioners onto routine electronic systems and extracted on
a daily and weekly basis.23 Over 3400 practices contrib-
ute to the system, which covers approximately 38% of
the UK population; most of the practices are in England
with fewer in Wales and Northern Ireland (NI). At the
time of the 2009 pandemic no Scottish practices contrib-
uted to the system. The density of coverage allows
reporting at country and regional levels. Regionally this
corresponds to 10 English Strategic Health Authorities
(SHAs) and 156 Primary Care Trusts (PCTs), which is
the lowest unit of healthcare provision in England with
an average population size of 350 000. The HPA/
Q-Surveillance data was provided as daily counts of
reported ILI cases in each PCT and estimated popula-
tion in each PCT for that day. This was aggregated to a
weekly scale and converted to incidence as rate of cases
per 100 000 population. HPA/QSurveillance data were
aggregated to three spatial resolutions; subregional,
regional and country level (corresponding to PCT, SHA
and England, Wales and NI, respectively).
Two measures of media interest and one of public
interest over time were compiled (table 1). Daily
national newspaper article counts were compiled from
the Lexis Nexis newspaper archive,24 counting articles
with headlines containing ‘swine ﬂu’ or ‘h1n1’. The
same search phrases were used to identify relevant arti-
cles on the Meltwater online database: this database
includes newspaper, online, television and radio news
articles and reporting.25 Internet search trends were
used as a proxy for public interest in the pandemic. This
was derived from Google Insight search facility,26 and
the daily relative volume of searches made where the
search terms contained the terms ‘swine ﬂu’ or ‘h1n1’
were collated.
Weekly unit sales of non-prescription retail products
for a major national UK retailer were obtained for the
period 28 January 2008 to 25 April 2010 (table 1).
These sales records were derived from a 10% sample of
transactions where a loyalty card was presented at the
point of purchase and were available at store level. Data
on individual product sales were extracted from a master
database and aggregated into six categories: Adult Cold
and Flu Remedies, Children’s Cold and Flu Remedies,
Cough Remedies, Thermometers, Anti-Viral Products
(including hand gel and wipes), Tissues. Sales as a pro-
portion of customer base were used instead of absolute
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sales to control for confounders such as changes in store
hours in the period of the study or variation in market
share between stores. Short shelf-life products were
assumed to be indicative of total customer base. Sales
were therefore adjusted in the ﬁrst instance by dividing
weekly total sales (for each category of product and
spatial scale) by the average weekly sales of milk and
bananas at the appropriate spatial scale (annual sales for
2008 and 2009 available).
The extreme seasonality associated with inﬂuenza
(and subsequently symptomatic remedies) in temperate
zones could introduce biases in the analysis. To adjust
for this, an underlying seasonal trend in proportional
sales was ﬁtted to log-transformed retail sales data from
the beginning of February 2008 to the end of January
2009. This was a prepandemic year, which we assumed
to be typical of the seasonal trend in inﬂuenza inci-
dence. A ﬂexible way to represent a seasonal trend is
through a sum of sine–cosine waves with frequencies cor-
responding to 1, 2, 3, etc cycles per year. For example,
the model with two sine–cosine pairs is















where yt is the retail sales data for each week of the year,
t, during 2008, α and β terms are the regression coefﬁ-
cients for each sine and cosine function, and ε is an
error term.
The model-ﬁtting process was repeated for each
product category at each spatial resolution. This resulted
in between one and four sine–cosine pairs across the dif-
ferent product groups. In each case, the ﬁtted seasonal
model was used to derive weekly residuals for each week
of the 2009 and 2010 data; these residuals, which are nor-
malised with respect to normal non-pandemic seasonal
sales, are used in the comparative analysis (see online
supplementary appendix table A1 and ﬁgure A1, A2).
Pearson’s correlation was performed between each
product category, national UK cases and media reporting.
Analysis was performed for the whole pandemic period as
well as the early pandemic period (6 April–1 June 2009,
media reporting only), summer pandemic wave (1 June–
30 August 2009, case and media reporting) and winter
pandemic wave (31 August 2009–14 February 2010, case
and media reporting). HPA/Q-Surveillance cases were
examined at different geographic scales and evaluated by
Pearson’s correlation coefﬁcients. For each product cat-
egory, correlation between residual sales and cases was
assessed for the period 4 May–9 November 2009. As a rise
in retail sales might be expected to occur before an out-
break is detected through healthcare-based surveillance
cross correlation with weekly time lags was also performed.
Spatial correlation was performed to look for evidence
of clustering of residual sales and inﬂuenza cases at
different time points. This was performed using the
‘spatial test’ function in R statistical language, included
in the GeoR package27: this calculates a test statistic by
Monte Carlo permutation testing for spatial autocorrel-
ation based on the use of variograms. For each product
group, this test statistic was calculated for subregional
residual sales. These spatial correlations were then exam-
ined as part of the weekly time series.
All data adjustment and analysis were performed using
R statistical software, V.2.15.2. Statistical signiﬁcance was
set at 95%.
RESULTS
During the declared pandemic period there were two
peaks of estimated cases in the summer and winter
seasons seen in national ﬂusurvey data (ﬁgure 1). HPA/
QSurveillance data at a national scale did not show a
winter peak. This is most likely due to the established
presence of the NPFS service which triaged ILI resulting
in a reduced number of primary care consultations.
Media reporting was high in the early pandemic period
(where there were relatively few cases in the UK) and
during the summer wave but was less during the winter
wave. Unadjusted national retail sales are shown in
ﬁgure 1 on a logarithmic scale.
There was a statistically signiﬁcant positive correlation
between thermometer and antiviral product sales and
national cases for the whole pandemic period (table 2).
When divided into summer and winter pandemic waves,
the correlation was stronger in the summer wave than the
winter wave. Children’s cold and ﬂu remedies were also
positively correlated with national cases during the summer
wave but not in the winter wave. Correlation between
weekly residual sales and weekly media reporting was also
performed (see table 2 and online supplementary table
A2). Thermometer and antiviral products were signiﬁcantly
positively correlated with media reporting for the whole
pandemic period (Cor 0.477 (95% CI 0.171 to 0.699); 0.711
(95% CI 0.495 to 0.844), respectively). No product group
sales were signiﬁcantly associated with media reporting in
the early pandemic period though the strength of correl-
ation was higher in the summer than the winter wave (see
table 2 and online supplementary table A2).
At a regional level there was no signiﬁcant correlation
between estimated inﬂuenza cases and retail sales of
adult ‘cold and ﬂu’ remedies, cough remedies or tissues.
There were weak but statistically signiﬁcant correlations
between sales of children’s remedies and cases in six
English regions and Wales (see online supplementary
table A3). Stronger positive correlations were seen
between thermometer and cases and hand-gel sales and
cases across all English regions and Wales (see online
supplementary table A3). No additional signiﬁcant cor-
relations were identiﬁed through cross-correlation ana-
lysis. The strongest correlation in cross-correlation
testing was for no lag (0 weeks) for all comparisons.
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At the subregional level there was a signiﬁcant posi-
tive correlation between thermometer and hand-gel
sales and cases in England (69.9%, 109/156; 71.8%,
112/156, respectively; ﬁgure 2). Several subregions had
a statistically signiﬁcant positive correlation between
cases and sales of adult ‘cold and ﬂu’ remedies (3.2%,
5/156) and cough remedies (3.8%, 6/156); however, a
greater number of subregions had a signiﬁcant
correlation between cases and children’s remedy sales
(35.6%, 55/156).
We found periods of signiﬁcant spatial structure
throughout the pandemic period for all sale products
(see online supplementary ﬁgure A3), particularly for
tissue and antiviral product sales which appear to have
more sustained periods of spatial patterning than the
other product types.
Table 1 Data sources of influenza case estimates, media reporting and public interest
Data Description Source Dates Reference
Flusurvey UK National Case
Estimates













UK newspaper headlines with reference to






UK newspaper headlines, radio and television





Google Trends UK Internet
Searches
Internet searches from UK IP addresses with




HPA, Health Protection Agency.
Figure 1 Top panel: weekly
estimated cases of influenza
shown are from English general
practitioner surveillance system
(Health Protection Agency
Q–Surveillance) and UK wide
estimates adjusted for changes in
care seeking behaviour (Flu
survey). Middle panel: weekly
sales per 100 000 customers of
six product groups from a national
UK retailer. Bottom panel: scaled
weekly estimates of UK media
interest (number of relevant
newspaper headlines
(LexisNexis) or newspaper, radio
and television articles
(Meltwater)); UK public interest is
represented by relative internet
search volume from Google
Search Trends.
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Table 2 Correlation between retail sales, national cases and media interest
Whole pandemic period (19
April 2009–14 February 2010)
Early pandemic (19 April–
31 May 2009)
Summer wave (01 June–30
August 2009)
Winter wave (31 August
2009–14 February 2010)
Cor 95% CI Cor 95% CI Cor 95% CI Cor 95% CI
FluSurvey Case Estimates
Adult cold and flu remedies 0.116 −0.216 to 0.424 – – 0.193 −0.401 to 0.672 0.149 −0.270 to 0.521
Childrens’ cold and flu remedies −0.023 −0.344 to 0.303 – – 0.778** 0.396 to 0.930 0.010 −0.395 to 0.412
Cough remedies 0.374* 0.056 to 0.622 – – 0.245 −0.353 to 0.702 0.396 −0.009 to 0.689
Thermometers 0.445** 0.142 to 0.672 – – 0.935*** 0.792 to 0.981 0.796*** 0.579 to 0.908
Antiviral products 0.072 −0.258 to 0.387 – – 0.671* 0.190 to 0.892 0.014 −0.392 to 0.415
Tissues 0.051 −0.278 to 0.369 – – 0.128 −0.455 to 0.634 −0.057 −0.450 to 0.354
Meltwater Reports
Adult cold and flu remedies −0.256 −0.488 to 0.010 −0.379 −0.855 to 0.444 0.151 −0.436 to 0.648 −0.399 −0.691 to 0.005
Childrens’ cold and flu remedies 0.171 −0.099 to 0.417 0.447 −0.376 to 0.876 0.576* 0.037 to 0.856 −0.427* −0.708 to −0.029
Cough remedies −0.225 −0.462 to 0.043 −0.447 −0.876 to 0.376 0.249 −0.350 to 0.703 −0.129 −0.506 to 0.290
Thermometers 0.364** 0.110 to 0.574 0.374 −0.449 to 0.854 0.772** 0.384 to 0.928 0.378 −0.030 to 0.678
Antiviral products 0.458*** 0.219 to 0.645 0.537 −0.270 to 0.901 0.516 −0.049 to 0.831 −0.119 −0.498 to 0.299
Tissues −0.288 −0.514 to −0.025 0.386 −0.437 to 0.858 0.241 −0.358 to 0.699 −0.451 −0.723 to −0.059
Google Searches
Adult cold and flu remedies 0.051 −0.269 to 0.360 −0.241 −0.808 to 0.559 0.258 −0.341 to 0.708 −0.214 −0.619 to 0.281
Childrens’ cold and flu remedies 0.369* 0.060 to 0.613 0.452 −0.371 to 0.877 0.716** 0.273 to 0.909 −0.303 −0.674 to 0.191
Cough remedies −0.050 −0.360 to 0.270 −0.318 −0.836 to 0.498 0.295 −0.306 to 0.728 −0.083 −0.529 to 0.399
Thermometers 0.661*** 0.437 to 0.808 0.212 −0.579 to 0.797 0.891*** 0.669 to 0.967 0.570* 0.140 to 0.819
Anti-viral products 0.562*** 0.299 to 0.745 0.346 −0.474 to 0.845 0.610* 0.089 to 0.869 0.038 −0.437 to 0.496























We analysed non-prescription retail sales data for a
major UK supermarket in comparison with pandemic
inﬂuenza syndromic case estimates within Great Britain
to assess the utility of purchase data to reﬂect case esti-
mates from existing surveillance methods. We found a
poor match between symptomatic remedies and cases at
the national scale for both summer and winter waves of
the pandemic. However, we found a signiﬁcant associ-
ation between children’s remedies and cases for the
summer wave at the national scale, and subregional
scales, where we found signiﬁcant association in 55 of
156 PCTs. Signiﬁcant positive correlations between cases
and sales of thermometers and anti-viral hand gels and
hand wash were seen at all spatial scales.
One concern about the use of retail sales as a surveil-
lance tool is that it may be more easily inﬂuenced by
factors other than symptomatic cases, such as heigh-
tened media coverage, and promotional activity by man-
ufacturers, supermarkets and government, than other
forms of reporting. The greatest press coverage occurred
during the early pandemic period where there were rela-
tively few cases of pandemic inﬂuenza in the UK. The
lack of correlation between sales and this heightened
coverage during this period suggests that ‘panic buying’
of symptomatic remedies or non-pharmacological
groups in response to media reports did not occur. The
lack of correlation between sales and media reports in
the winter suggests that sales were more driven by cases
than media reports as there was a similar level of cases
in the summer and winter periods.
The use of sales information for adult and child
remedy products has been suggested as a useful aug-
mentation to traditional surveillance mechanisms,8 13 14
but has not been tested within the UK. Previous studies
have suggested that localised retail sales data is more
reﬂective of surveyed inﬂuenza patterns than national
level data.11 12 28 Our results broadly support these
observations. Some products may be more useful than
others in their relative ability to reﬂect underlying
disease incidence.29 Our results suggest that children’s
remedies may better reﬂect community infection pat-
terns than adult products. This may be due to children
being at higher risk of infection with 2009 pandemic
inﬂuenza than adults,30 being more likely to be symp-
tomatic,31 32 or may reﬂect adult–parent differences in
self-medication practices.33 We ﬁnd no evidence that
retails sales may detect cases earlier than established sur-
veillance systems, though our analysis is limited by data
resolved at a weekly scale.
Sales of antiviral products and thermometers were
highly associated with both pandemic inﬂuenza cases
and media and public interest measures, especially
during the ﬁrst ‘summer’ wave of the pandemic. This
Figure 2 Correlations between sales of six product categories and influenza A H1N1/pdm cases during 2009. Points relate to a
geographic region, size of the point and depth of colour is related to the strength of the correlation.
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ﬁnding was not replicated in tissue sales and may reﬂect
larger unit sales per 100 000 customers making signals
harder to detect. The use of antiviral products and ther-
mometers (for self-diagnosis) were recommended by
UK government public health messaging during the
early months of the pandemic and throughout the pan-
demic.19 Cross-sectional telephone surveys have gener-
ally reported low level of uptake of public health
advice34 35 but there is some evidence that this is a poor
indicator of actual behaviour when more objective mea-
sures are used.36 We believe our results are the ﬁrst
national-scale evidence that the public actively
responded to these messages, at least through the pur-
chasing of such products, and provides an alternative
objective measure of public response to health advice.
There are several limitations to this study. The sales
data used here are derived from the shopping purchases
of a sample of shopping baskets, and only from pur-
chases involving presentation of a loyalty card. The sales
data are only sourced from one supermarket chain, and
while that chain has one of the largest market shares
nationally in the UK, many non-prescription purchases
are likely to be made in other outlets (such as dedicated
pharmacies) which may better reﬂect community inci-
dence of infection. The available sales data, while
resolved to purchases made at an individual store level,
was only available at a weekly time resolution preventing
more ﬁnely resolved temporal analysis. Sales of antipyr-
etic medication not branded as ‘cold and ﬂu remedies’
were excluded from our analysis because of concerns
regarding the interpretation of signals from these pro-
ducts. Remedy products may be purchased for a variety
of reasons other than to directly medicate against infec-
tion with inﬂuenza: they could be used for symptom
alleviation for a range of other pathogen infections and
conditions. We do not know if and how purchasing pat-
terns reﬂect the use of the products themselves: indivi-
duals may use previously purchased products at the
onset of new symptoms, only purchasing products when
these expire, rather than buying new products to treat a
new illness. We did not have access to surveillance data
at PCT level for the full pandemic period, which would
have been very valuable. The case data to which we com-
pared the retail sales information is largely based on
diagnosis of ILI cases (syndromic illness) and not viro-
logically conﬁrmed cases. Case data used in this analysis
were not stratiﬁed by age; we were therefore unable to
perform a more appropriate comparison of case data
with adult and children products. Purchasing patterns
made over a greater number of years and inﬂuenza
seasons could have improved the seasonality estimation
of purchasing behaviour.
The pandemic of 2009 was of a mild strain, which did
not appear to generate a large volume of community
cases which self-medicated using OTC remedies and
which did not present to existing surveillance mechan-
isms. However, at particular spatial scales and in particu-
lar age-groups, or (we suggest) for more severe strains,
retail sales may help augment existing surveillance
mechanisms to provide a quantitative indication of care-
seeking behaviour. However, there remain considerable
uncertainties in the speciﬁc usage and self-medicating
behaviour of individuals in relation to infection and pur-
chasing of products: further investigation is required
prior to the use of sales data for surveillance purposes.
CONCLUSIONS
Retail sales of over-the-counter symptom remedies at a
national level are unlikely to be useful for the detection of
cases. However, at more ﬁnely resolved spatial scales and
in particular age-groups retail sales may help augment
existing inﬂuenza surveillance and merit further study.
Our study demonstrates that the retail sales patterns of par-
ticular product types, such as personal hygiene and self-
diagnosis products, can be of value in assessing public
responses to regional and national health messaging.
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